Related Experiment Video
Updated: Jul 17, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
Integrative Analysis of Androgen Receptor Interactors Aberrations and Associated Prognostic Significance in Prostate
Zhu Wang1, Ying Zhang2, Qiong Deng3
1Urology Department, Affiliated Hospital of Longhua Shenzhen, Southern Medical University, Shenzhen, Guangdong 518109, China. wangzhu1223@hotmail.com.
Purpose:
Much progress has been made by directing against the adrogen receptor (AR) pathway in the treatment of prostate cancer in past decades. However, AR-interactors related metastatic castration resistant prostate cancer eventually developed. Here, we aimed to characterize the aberrations and therapeutic implication in advanced disease.
Materials And Methods:
STRING database, UALCAN web portal and cBioPortal platform was used to analyze the AR interaction network, gene alterations, as well as the prognostic significance. GO and KEEG analysis was performed to characterize the functional enrichment of the identified AR-interactors.
Results:
Ten first shell AR-interactors were identified, among of which FOXA1 and PELP1 was significantly up-regulated, while CCND1, CTNNB1, NCOA4 and HSP90AA1 exhibited a significantly decreased pattern. The median survival period of altered group (n = 227) was 70 months (95% CI, 60-105M), while that of non-altered group (n = 545) was 141 months (95% CI, 115.13-NA, P < 0.001). GO and KEGG enrichment showed that the identified AR-interactors were particularly enriched in prostate cancer and thyroid hormone signaling pathway, as well as endocrine resistance.
Conclusion:
The AR-interactors might be useful markers for prostate cancer diagnosis and prognosis, and provide a new sight for revealing the molecular mechanism of CRPC progression.
Insights
Aberrations in androgen receptor (AR) interactors are linked to poor prognosis in advanced prostate cancer. These AR interactors may serve as biomarkers for diagnosing and understanding metastatic castration-resistant prostate cancer (CRPC).
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Significant advancements have been made in targeting the androgen receptor (AR) pathway for prostate cancer treatment.
- However, the development of AR-interactor-related metastatic castration-resistant prostate cancer (CRPC) remains a clinical challenge.
Purpose of the Study:
- To characterize AR-interactor aberrations in advanced prostate cancer.
- To investigate the therapeutic implications of these aberrations.
Main Methods:
- Utilized the STRING database, UALCAN web portal, and cBioPortal platform to analyze the AR interaction network, gene alterations, and prognostic significance.
- Performed Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis for functional enrichment of AR-interactors.
Main Results:
- Identified ten first-shell AR-interactors, with FOXA1 and PELP1 significantly upregulated, and CCND1, CTNNB1, NCOA4, and HSP90AA1 significantly downregulated.
- The median survival for the altered group (n=227) was 70 months, compared to 141 months for the non-altered group (n=545) (P < 0.001).
- Enrichment analysis revealed AR-interactors are notably enriched in prostate cancer, thyroid hormone signaling, and endocrine resistance pathways.
Conclusions:
- AR-interactors show potential as diagnostic and prognostic markers for prostate cancer.
- These findings offer new insights into the molecular mechanisms driving CRPC progression.
Related Concept Videos
Abnormal Proliferation
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Internal Receptors
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

